Liminatus Pharma, Inc. (LIMN)
0.708
-0.03
(-4.06%)
USD |
NASDAQ |
Dec 24, 16:00
Liminatus Pharma EPS Diluted (Quarterly): -0.0675 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Oruka Therapeutics, Inc. | -0.6871 |
| Maze Therapeutics, Inc. | -0.6258 |
| MapLight Therapeutics, Inc. | -0.6484 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.823M |
| Total Expenses (Quarterly) | 1.823M |
| Enterprise Value | 19.88M |
| Earnings Yield | -26.17% |
| Normalized Earnings Yield | -24.32 |